Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz

Patent Law

: IPBiz

Mylan sued by Schering over Simvastatin

By Lawrence B. Ebert, Esq.

In a Hatch-Waxman action, Mylan has been sued by Schering Corporation and MSP Singapore Company in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) [with a paragraph IV certification] with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg.

Full post as published by IPBiz on December 22, 2009 (boomark / email).